The phase 3 TETON-2 ( NCT05255991) clinical trial assessed inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) and ...

As physician shortages and burnout threaten the patient experience in oncology, The US Oncology Network works to scale ...

The CDC’s Opioid Prescribing Guidelines initially stirred a significant amount of controversy among health care organizations ...

Payers and providers have long eyed each other with suspicion, but a growing cohort of health system leaders say that ...

New reports spotlight inequities—from Black maternal mortality to 988’s youth impact—as well as rising cancer risk and gaps ...

Bispecific antibodies are delivering unprecedented response rates in multiple myeloma, offering fast, flexible options ...

A panel featured during the NAACOS Spring 2026 Conference featured 3 experts discussing different methods of encouraging more ...

Chris Johnson, MBA, founder and CEO of Bluebird Kids Health, identifies the emergence of "pediatric care deserts" as a ...

Bean announced 2 legislative responses: the PROMPT Act, which would send beneficiaries a monthly statement of Medicare claims ...

Off-the-shelf cema-cel clears MRD at more than triple the rate of observation alone—and may propel a shift to frontline use ...

Formerly known as DB-OTO, lunsotogene parvec is an adeno-associated virus (AAV) vector–based gene therapy administered via a ...

Patent expirations are increasingly concentrated in specialty, with >$43B in 2026 brand sales exposed and meaningful ...